Literature DB >> 2686545

Treatment of genitourinary tract infections with fluoroquinolones: activity in vitro, pharmacokinetics, and clinical efficacy in urinary tract infections and prostatitis.

J S Wolfson1, D C Hooper.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2686545      PMCID: PMC172733          DOI: 10.1128/AAC.33.10.1655

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  68 in total

1.  The efficacy and safety of ciprofloxacin in the treatment of chronic Pseudomonas aeruginosa urinary tract infection.

Authors:  E M Brown; R Morris; T P Stephenson
Journal:  J Antimicrob Chemother       Date:  1986-11       Impact factor: 5.790

2.  Single-dose ciprofloxacin at 100 versus 250 mg for treatment of uncomplicated urinary tract infections in women.

Authors:  F Garlando; S Rietiker; M G Täuber; M Flepp; B Meier; R Lüthy
Journal:  Antimicrob Agents Chemother       Date:  1987-02       Impact factor: 5.191

3.  Treatment of chronic bacterial prostatitis with ciprofloxacin. Results of a one-year follow-up study.

Authors:  W Weidner; H G Schiefer; A Dalhoff
Journal:  Am J Med       Date:  1987-04-27       Impact factor: 4.965

4.  Comparison of ciprofloxacin and beta-lactam antibiotics in the treatment of urinary tract infections and alteration of fecal flora.

Authors:  G L Daikos; S B Kathpalia; R Sharifi; V T Lolans; G G Jackson
Journal:  Am J Med       Date:  1987-04-27       Impact factor: 4.965

5.  Oral ciprofloxacin in the treatment of elderly patients with complicated urinary tract infections due to trimethoprim/sulfamethoxazole-resistant bacteria.

Authors:  L C Preheim; T A Cuevas; J S Roccaforte; M A Mellencamp; M J Bittner
Journal:  Am J Med       Date:  1987-04-27       Impact factor: 4.965

6.  Clinical experience with ofloxacin in urinary tract infection.

Authors:  C E Cox; S V Callery; K J Tack
Journal:  Infection       Date:  1986       Impact factor: 3.553

Review 7.  Review of the bioavailability and pharmacokinetics of oral norfloxacin.

Authors:  G E Stein
Journal:  Am J Med       Date:  1987-06-26       Impact factor: 4.965

Review 8.  Ofloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  J P Monk; D M Campoli-Richards
Journal:  Drugs       Date:  1987-04       Impact factor: 9.546

9.  Comparison of ciprofloxacin and co-trimoxazole in the treatment of uncomplicated urinary tract infection in women.

Authors:  N K Henry; H J Schultz; N C Grubbs; S M Muller; D M Ilstrup; W R Wilson
Journal:  J Antimicrob Chemother       Date:  1986-11       Impact factor: 5.790

10.  Ciprofloxacin and co-trimoxazole in urinary tract infection.

Authors:  A H Williams; R N Grüneberg
Journal:  J Antimicrob Chemother       Date:  1986-11       Impact factor: 5.790

View more
  14 in total

Review 1.  Treatment of genitourinary tract infections with fluoroquinolones: clinical efficacy in genital infections and adverse effects.

Authors:  D C Hooper; J S Wolfson
Journal:  Antimicrob Agents Chemother       Date:  1989-10       Impact factor: 5.191

2.  Oral ciprofloxacin versus ceftriaxone for the treatment of urethritis from resistant Neisseria gonorrhoeae in Zambia.

Authors:  J P Bryan; S K Hira; W Brady; N Luo; C Mwale; G Mpoko; R Krieg; E Siwiwaliondo; C Reichart; C Waters
Journal:  Antimicrob Agents Chemother       Date:  1990-05       Impact factor: 5.191

3.  Chronic bacterial prostatitis: therapeutic experience with ciprofloxacin.

Authors:  W Weidner; H G Schiefer
Journal:  Infection       Date:  1991       Impact factor: 3.553

Review 4.  Intracellular concentrations of antibacterial agents and related clinical implications.

Authors:  J D Butts
Journal:  Clin Pharmacokinet       Date:  1994-07       Impact factor: 6.447

5.  Comparative efficacies of ofloxacin, cefotaxime, and doxycycline for treatment of experimental epididymitis due to Escherichia coli in rats.

Authors:  E Vieler; C Jantos; H L Schmidts; W Weidner; H G Schiefer
Journal:  Antimicrob Agents Chemother       Date:  1993-04       Impact factor: 5.191

6.  Fluorescence quenching as a tool to investigate quinolone antibiotic interactions with bacterial protein OmpF.

Authors:  Patrícia Neves; Isabel Sousa; Mathias Winterhalter; Paula Gameiro
Journal:  J Membr Biol       Date:  2009-01-16       Impact factor: 1.843

7.  Use of ciprofloxacin versus use of aminoglycosides for therapy of complicated urinary tract infection: prospective, randomized clinical and pharmacokinetic study.

Authors:  G D Fang; C Brennen; M Wagener; D Swanson; M Hilf; L Zadecky; J DeVine; V L Yu
Journal:  Antimicrob Agents Chemother       Date:  1991-09       Impact factor: 5.191

Review 8.  Use of quinolones in treatment of prostatitis and lower urinary tract infections.

Authors:  V T Andriole
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-04       Impact factor: 3.267

9.  Ofloxacin versus doxycycline for treatment of cervical infection with Chlamydia trachomatis.

Authors:  T M Hooton; B E Batteiger; F N Judson; S L Spruance; W E Stamm
Journal:  Antimicrob Agents Chemother       Date:  1992-05       Impact factor: 5.191

10.  Single-dose and three-day regimens of ofloxacin versus trimethoprim-sulfamethoxazole for acute cystitis in women.

Authors:  T M Hooton; C Johnson; C Winter; L Kuwamura; M E Rogers; P L Roberts; W E Stamm
Journal:  Antimicrob Agents Chemother       Date:  1991-07       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.